UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2024
Commission File Number: 001-33765
AIRNET TECHNOLOGY INC.
(Exact name of registrant as specified in its
charter)
Suite 301
No. 26 Dongzhimenwai Street
Chaoyang District, Beijing 100027
The People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x
Form 40-F ¨
EXPLANATORY NOTE
The
document attached as Exhibit 99.1 to this report on Form 6-K is hereby incorporated by reference into the Company’s Registration
Statement on Form F-3, as amended, initially filed with the U.S. Securities and Exchange Commission on May 10, 2024 (Registration No. 333-279318), and
shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports
subsequently filed or furnished.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
AIRNET TECHNOLOGY INC. |
|
|
|
Date: September 20, 2024 |
By: |
/s/ Fuying Yan |
|
Name: |
Fuying Yan |
|
Title: |
Co-Chief Executive Officer |
EXHIBIT INDEX
Exhibit 99.1
AirNet Announces Receipt of Deficiency Letters
from Nasdaq
BEIJING, September 20, 2024 /PRNewswire/
– AirNet Technology Inc., formerly known as AirMedia Group Inc. (“AirNet” or the “Company”) (Nasdaq: ANTE),
today announced that it received two deficiency letters (the “Deficiency Letters”) from the Listing Qualifications Department
of The Nasdaq Stock Market Inc. (“Nasdaq”) both dated on September 18, 2024 indicating that (1) the Company is no
longer in compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules as
the Company’s closing bid price per American depositary share (“ADS”), each representing one ordinary share of the Company,
has been below $1.00 for a period of 30 consecutive business days, and (2) the Company is no longer in compliance with Rule 5550(a)(5) of
the Nasdaq Listing Rules for continued listing due to its failure to maintain a minimum Market Value of Publicly Held Shares
(“MVPHS”) of US$1.0 million for a period of 30 consecutive business days.
The Deficiency Letters have no immediate impact
on the Company’s listing on the Nasdaq Capital Market. Pursuant to Rules 5810(c)(3)(A) and 5810(c)(3)(D) of the Nasdaq
Listing Rules, respectively, the Company has a compliance period of 180 calendar days, or until March 17, 2025 (the “Compliance
Period”), to regain compliance with Nasdaq's minimum bid price and minimum MVPHS requirements. If at any time during the Compliance
Period, the closing bid price per ADS is at least $1.00 for a minimum of ten consecutive business days, Nasdaq will provide the Company
a written confirmation of compliance with the minimum bid price requirement, and the matter will be closed. If at any time during
the Compliance Period, the Company’s MVPHS is at least US$1.0 million for a minimum of ten consecutive business days, Nasdaq will
provide the Company a written confirmation of compliance with the minimum MVPHS requirement, and the matter will be closed.
If the Company does not regain compliance with
the minimum bid price requirement by March 17, 2025, the Company may be eligible for additional time to regain compliance. To
qualify, the Company must meet the continued listing requirements for MVPHS and all other initial listing standards, with the exception
of bid price requirement, of the Nasdaq Capital Market, and provides written notice to Nasdaq of its intention to cure the deficiency,
including by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will grant an additional 180
calendar days to the Company (the “Second Compliance Period”). However, if Nasdaq concludes that the Company will not be able
to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will
be subject to delisting. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten business
days prior to March 17, 2025, or the expiration of the Second Compliance Period if granted.
In the event the Company does not regain compliance
with the minimum MVPHS requirement by March 17, 2025, the Company will receive written notification that its securities are
subject to delisting. In the event of such notification, the Company may appeal Nasdaq’s determination to delist its securities,
but there can be no assurance Nasdaq would grant the Company’s request for continued listing.
This announcement is made in compliance with the Nasdaq Listing Rule 5810(b),
which requires prompt disclosure of receipt of a notification of deficiency.
Forward-Looking Statements
This announcement contains forward-looking statements within the meaning
of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified
by terminology such as “will,” “expects,” “is expected to,” “anticipates,” “aim,”
“future,” “intends,” “plans,” “believes,” “are likely to,” “estimates,”
“may,” “should” and similar expressions. The Company may also make written or oral forward-looking statements
in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press
releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking
statements are based upon management’s current expectations and current market and operating conditions, and involve inherent risks
and uncertainties, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause its
actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information is
included in the Company’s filings with the U.S. Securities and Exchange Commission. All information provided in this announcement
is as of the date of this announcement, and the Company does not undertake any obligation to update any forward-looking statement as a
result of new information, future events or otherwise, except as required under law.
Company Contact
Penny Pei
Investor Relations
AirNet Technology Inc.
Tel: +86-10-8460-8678
Email: penny@ihangmei.com
AirNet Technology (NASDAQ:ANTE)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
AirNet Technology (NASDAQ:ANTE)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024